Diagnostic tools and technologies for infectious and non-communicable diseases in low-and-middle-income countries

Health and Technology

Volumn 3, Issue 4, 2013, Pages 271-281

  Novak, M T ^a   Kotanen, C N ^b   Carrara, S ^c   Guiseppi Elie, A ^b,d   Moussy, F G ^e  

^a Duke University   (United States)

^b CLEMSON UNIVERSITY   (United States)

^c EPFL   (Switzerland)

^d Clemson University   (United States)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

ASSURED; Lateral flow devices; Low cost diagnostics; Micro TAS; Paper diagnostics

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HEMOGLOBIN A1C; MILTEFOSINE; NANOCRYSTAL; PAROMOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL THERAPY; ARTICLE; BIOCHIP; BIOMEDICAL MICROELECTROMECHANICAL SYSTEM; CD4 LYMPHOCYTE COUNT; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COST MINIMIZATION ANALYSIS; DIABETES MELLITUS; DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELECTRODE; EQUIPMENT DESIGN; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPEDANCE; INFECTION; ISCHEMIC HEART DISEASE; LABORATORY DIAGNOSIS; LATERAL FLOW DIAGNOSTIC DEVICE; LOWEST INCOME GROUP; MALARIA; MEDICAL TECHNOLOGY; MICROFLUIDICS; MOBILE PHONE; NANOTECHNOLOGY; NON COMMUNICABLE DISEASE; PAPER DIAGNOSTICS; PATIENT CARE; PREGNANCY TEST; QUANTITATIVE DIAGNOSIS; SEMICONDUCTOR; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; VISCERAL LEISHMANIASIS; WORLD HEALTH ORGANIZATION;

EID: 84889240019     PISSN: 21907188     EISSN: 21907196     Source Type: Journal    
DOI: 10.1007/s12553-013-0060-9     Document Type: Article

References (51)

1. Turner AP, Chen B, Piletsky SA. In vitro diagnostics in diabetes: meeting the challenge. Clin Chem. 1999;45:1596-601.
2. Kotanen CN, Moussy FG, Carrara S, Guiseppi-Elie A. Implantable enzyme amperometric biosensors. Biosens Bioelectron. 2012;35:14-26.
3. World Health Organization. Diabetes, Fact Sheet no. 312. World Health Organization 2011.
4. http://www.idf.org/diabetesatlas/5e/Update2012. 2012. IDF Diabetes Atlas Update 2012. International Diabetes Federation.
5. Peeling RW, Smith PG, Bossuyt PM. A guide for diagnostic evaluations. Nat Rev Microbiol. 2006;4:S2-6.
6. Mukenge-Tshibaka L, Alary M, Lowndes CM, Van Dyck E, Guedou A, Geraldo N, et al. Syndromic versus laboratory-based diagnosis of cervical infections among female sex workers in Benin: implications of nonattendance for return visits. Sex Transm Dis. 2002;29:324-30.
7. http://www.who.int/neglected-diseases/en/. 2012. Neglected tropical diseases WHO, http://www.who.int/neglected-diseases/en/.
8. http://www.who.int/malaria/en/. 2012. Malaria WHO, Geneva, Switzerland.
9. http://www.globalforumhealth.org/about/1090-gap/. 2012. 10/90 gap. Global forum for health research.
10. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005-15.
11. http://www.who.int/topics/millennium-development-goals/diseases/en/. 2012. MDG 6: combat HIV/AIDS, malaria and other diseases. World Health Organization, Geneva, Switzerland.
12. http://policycures.org/news.html. 2012. Fifth Annual G-FINDER Survey Report. Policy Cures Sydney, Australia.
13. http://www.who.int/chp/ncd-global-status-report/en/. 2012. Global Status Report on NCDs. World Health Organization, Geneva, Switzerland.
14. World Health Organization. Cancer, Fact Sheet no. 297. World Health Organization 2012.
15. Peeling RW, Holmes KK, Mabey D, Ronald A. Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect. 2006;82:v1-6.
16. Deborah C, Burgess H, Wasserman J, Dahl CA, Girosi F, Olmsted SS. et al. 2007. Estimating the Global Health Impact of Improved Diagnostic Tools for the Developing World, p. http://www.rand.org/pubs/research-briefs/RB9293. RAND Corporation, Santa Monica, CA, USA.
17. Yetisen AK, Akram MS, Lowe CR. Paper-based microfluidic point-of-care diagnostic devices. Lab on a Chip 2013.
18. Martinez AW, Phillips ST, Whitesides GM, Carrilho E. Diagnostics for the developing world: microfluidic paper-based analytical devices. Anal Chem. 2009;82:3-10.
19. Martinez AW, Phillips ST, Butte MJ, Whitesides GM. Patterned paper as a platform for inexpensive, Low-volume, portable bioassays. Angew Chem Int Ed. 2007;46:1318-20.
20. Noh H, Phillips ST. Metering the capillary-driven flow of fluids in paper-based microfluidic devices. Anal Chem. 2010;82:4181-7.
21. Wang H-Y, Bernarda A, Huang C-Y, Lee D-J, Chang J-S. Micro-sized microbial fuel cell: a mini-review. Bioresour Technol. 2011;102:235-43.
22. Lankelma J, Nie Z, Carrilho E, Whitesides GM. Paper-based analytical device for electrochemical flow-injection analysis of glucose in urine. Anal Chem. 2012;84:4147-52.
23. Dungchai W, Chailapakul O, Henry CS. Electrochemical detection for paper-based microfluidics. Anal Chem. 2009;81:5821-6.
24. Khan MS, Thouas G, Shen W, Whyte G, Garnier G. Paper diagnostic for instantaneous blood typing. Anal Chem. 2010;82:4158-64.
25. Sewart R, Gärtner C, Klemm R, Schattschneider S, Becker H. Microfluidic device for fast on-site biomedical diagnostic on the example of lithium analysis in blood 2012.
26. Lu J, Ge S, Ge L, Yan M, Yu J. Electrochemical DNA sensor based on three-dimensional folding Paper device for specific and sensitive point-of-care testing. Electrochimica Acta 2012.
27. Vella SJ, Beattie P, Cademartiri R, Laromaine A, Martinez AW, Phillips ST, et al. Measuring markers of liver function using a micropatterned paper device designed for blood from a fingerstick. Anal Chem. 2012;84:2883-91.
28. Martinez AW, Phillips ST, Nie Z, Cheng CM, Carrilho E, Wiley BJ, et al. Programmable diagnostic devices made from paper and tape. Lab Chip. 2010;10:2499-504.
29. Schilling KM, Lepore AL, Kurian JA, Martinez AW. Fully enclosed microfluidic paper-based analytical devices. Anal Chem. 2012;84:1579-85.
30. Nie Z, Deiss F, Liu X, Akbulut O, Whitesides GM. Integration of paper-based microfluidic devices with commercial electrochemical readers. Lab Chip. 2010;10:3163-9.
31. http://www.dfa.org/index.php. 2012. Diagnostics For All, Inc., p. Diagnostics For All, Inc.
32. Chen J, Steckl AJ, Loboda MJ. Molecular beam epitaxy growth of SiC on Si(111) from silacyclobutane. J Vac Sci Technol B: Microelectron Nanometer Struct. 1998;16:1305-8.
33. Severe P, Juste MA, Ambroise A, Eliacin L, Marchand C, Apollon S, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med. 2010;363:257-65.
34. Boyle DS, Hawkins KR, Steele MS, Singhal M, Cheng X. Emerging technologies for point-of-care CD4 T-lymphocyte counting. Trends Biotechnol. 2012;30:45-54.
35. Watkins NN, Sridhar S, Cheng X, Chen GD, Toner M, Rodriguez W, et al. A microfabricated electrical differential counter for the selective enumeration of CD4+ T lymphocytes. Lab Chip. 2011;11:1437-47.
36. Cheng X, Gupta A, Chen C, Tompkins RG, Rodriguez W, Toner M. Enhancing the performance of a point-of-care CD4+ T-cell counting microchip through Monocyte depletion for HIV/AIDS diagnostics. Lab Chip. 2009;9:1357-64.
37. Cheng X, Liu Y-S, Irimia D, Demirci U, Yang L, Zamir L, et al. Cell detection and counting through cell lysate impedance spectroscopy in microfluidic devices. Lab Chip. 2007;7:746-55.
38. Chin CD, Linder V, Sia SK. Commercialization of microfluidic point-of-care diagnostic devices. Lab Chip. 2012;12:2118-34.
39. http://www.daktaridx.com/about/. 2012. Daktari Diagnostics, Inc.
40. Rodriguez WR, Christodoulides N, Floriano PN, Graham S, Mohanty S, Dixon M, et al. A microchip CD4 counting method for HIV monitoring in resource-poor settings. PLoS Med. 2005;2:e182.
41. Moon S, Gurkan UA, Blander J, Fawzi WW, Aboud S, Mugusi F, et al. Enumeration of CD4 < sup > + T-Cells Using a Portable Microchip Count Platform in Tanzanian HIV-Infected Patients. PLoS One. 2011;6:e21409.
42. Jokerst JV, Floriano PN, Christodoulides N, Simmons GW, McDevitt JT. Integration of semiconductor quantum dots into nano-bio-chip systems for enumeration of CD4+ T cell counts at the point-of-need. Lab Chip. 2008;8:2079-90.
43. Jokerst JV, Jacobson JW, Bhagwandin BD, Floriano PN, Christodoulides N, McDevitt JT. Programmable Nano-Bio-Chip Sensors: Analytical Meets Clinical. Anal Chem. 2010;82:1571-9.
44. Ferris NP, Nordengrahn A, Hutchings GH, Paton DJ, Kristersson T, Brocchi E, et al. Development and laboratory validation of a lateral flow device for the detection of serotype SAT 2 foot-and-mouth disease viruses in clinical samples. J Virol Methods. 2010;163:474-6.
45. Carrara S, Ghoreishizadeh S, Olivo J, Taurino I, Baj-Rossi C, Cavallini A, et al. Fully Integrated Biochip Platforms for Advanced Healthcare. Sensors. 2012;12:11013-60.
46. Lingerfelt L, Karlinsey J, Landers J, Guiseppi-Elie A. Impedimetric Detection for DNA Hybridization within Microfluidic Biochips, p. 103-120. In P. Floriano (editor), Microchip-Based Assay Systems. Humana Press; 2007.
47. Mitchell K.J, Bull S, Kiwanuka J, Ybarra M.L. Cell phone usage among adolescents in Uganda: acceptability for relaying health information. Health Education Research 2011.
48. Fox K. Africa's mobile economic revolution. The Guardian, UK: The Observer; 2011.
49. Årsand E, Tatara N, Østengen G, Hartvigsen G. Mobile phone-based self-management tools for type 2 diabetes: the few touch application. J Diabetes Sci Technol. 2010;4:328-36.
50. World Health Organization. WHO Prequalification of Diagnostics Programme. World Health Organization 2011.
51. Mehregany M, Zorman CA, Rajan N, Wu CH. Silicon carbide MEMS for harsh environments. Proc IEEE. 1998;86:1594-610.